Share

MeiraGTx Netherlands B.V

General company profile

MeiraGTx Netherlands B.V. is an Amsterdam based biopharmaceutical company developing local gene therapy for different indications.

Company activities:

The company specializes in the development of viral gene therapy vectors, in particular adeno-associated virus (AAV) based therapeutics. Our goal is to develop potentially curative treatments for patients living with serious diseases. Several product candidates are in the discovery and development phase. MeiraGTx Netherlands B.V. is a wholly-owned subsidiary of MeiraGTx Holdings plc. With sites in New York, London, Shannon and Amsterdam, our global footprint provides us the opportunity to partner with leading institutions around the world, allowing us to deepen our understanding of diseases and their progression.

Company info

logo
Address
Paalbergweg 2
1105 AG Amsterdam
The Netherlands
Type of organisation
Multinational

Create a job alert

Would you like to receive the latest vacancies in your e-mail box? Create a job alert based on your keyword(s) and preferences.

Sign up

Hyphen Projects uses cookies to remember certain preferences and align interests.
By continuing to use this site, you consent to our use of cookies.